Donna Sherringham Appointed Interim Chief Executive of GV Health
GV Health is pleased to announce the appointment of Donna Sherringham as Interim Chief Executive, commencing 30 November 2026.
Currently serving as GV Health’s Chief Operating Officer, Ms Sherringham brings extensive leadership experience and a deep understanding of regional healthcare to the role. Ms Sherringham has been a member of the organisation’s Executive team since joining GV Health in 2013, and currently oversees all clinical operations including emergency, medical, surgical, critical care, women’s and children’s health, aged care, allied health, pathology, pharmacy and radiology services.
GV Health Board Chair, Michael Delahunty, said Ms Sherringham’s experience, leadership and commitment to the community made her well placed to lead the organisation during the transition period.
“Donna is a highly respected healthcare leader who has made a significant contribution to GV Health and the broader region over many years,” Mr Delahunty said.
“Donna’s strong clinical background, proven leadership and deep understanding of our organisation will ensure stability and a continued focus on delivering high-quality care for our patients and communities.”
Ms Sherringham said she was honoured to take on the role of Interim Chief Executive.
“It is a privilege to lead an organisation that plays such an important role in the health and wellbeing of our community,” Ms Sherringham said.
“My focus during the interim period will be on supporting our staff, progressing GV Health’s key priorities and maintaining continuity across our services. I look forward to working closely with the Board and our outstanding team to build on the work underway and continue delivering high-quality care for our communities.”
Ms Sherringham began her career as a Division 1 nurse and has held senior clinical and executive leadership positions across metropolitan and regional health services. Ms Sherringham holds a Diploma of Applied Science, a Bachelor of Nursing from Monash University and a Master of Health Care Administration. Her career has been marked by a strong commitment to improving access to healthcare for regional communities.
During her time at GV Health, Ms Sherringham has overseen the expansion of a range of specialist services, including the establishment of the Paediatric Allergy Clinic and the launch of a public IVF service in partnership with the Royal Women’s Hospital, helping improve access to care closer to home for local families.
The GV Health Board thanks outgoing Chief Executive Matt Sharp for his leadership and contribution to the organisation and wishes him well in his future endeavours. Mr Sharp will continue as Chief Executive until his tenure concludes on 27 November 2026.
The Board looks forward to working with Ms Sherringham over the coming weeks as recruitment progresses to appoint GV Health’s next Chief Executive.
